Learn More
Selleck Chemical LLC LTI-291 S1024-25mg

Supplier: Selleck Chemical LLC S102425MG
LTI-291 is the first small-molecule activator of Glucocerebrosidase(GCase) for the treatment of parkinson s disease
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.